Literature DB >> 17017516

A short overview on the role of alpha-synuclein and proteasome in experimental models of Parkinson's disease.

F S Giorgi1, A Bandettini di Poggio, G Battaglia, A Pellegrini, L Murri, S Ruggieri, A Paparelli, F Fornai.   

Abstract

The Ubiquitin Proteasome System is a multi-enzymatic pathway which degrades polyubiquinated soluble cytoplasmic proteins. This biochemical machinery is impaired both in sporadic and inherited forms of Parkinsonism. In the present paper we focus on the role of the pre-synaptic protein alpha-synuclein in altering the proteasom based on the results emerging from experimental models showing a mechanistic chain of events between altered alpha-synuclein, proteasome impairment and formation of neuronal inclusions and catecholamine cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17017516     DOI: 10.1007/978-3-211-45295-0_17

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

1.  Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease.

Authors:  Anil Kachroo; Michael A Schwarzschild
Journal:  Ann Neurol       Date:  2012-02       Impact factor: 10.422

Review 2.  The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.

Authors:  Filippo Sean Giorgi; Francesca Biagioni; Paola Lenzi; Alessandro Frati; Francesco Fornai
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

3.  Motor Neurons Pathology After Chronic Exposure to MPTP in Mice.

Authors:  Giorgio Vivacqua; Francesca Biagioni; Carla L Busceti; Michela Ferrucci; Michele Madonna; Larisa Ryskalin; Shun Yu; Loredana D'Este; Francesco Fornai
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

4.  Reducing synuclein accumulation improves neuronal survival after spinal cord injury.

Authors:  Stephanie M Fogerson; Alexandra J van Brummen; David J Busch; Scott R Allen; Robin Roychaudhuri; Susan M L Banks; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan; Jennifer R Morgan
Journal:  Exp Neurol       Date:  2016-02-13       Impact factor: 5.330

5.  Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells.

Authors:  Derek B Oien; Heather E Shinogle; David S Moore; Jackob Moskovitz
Journal:  J Mol Neurosci       Date:  2009-08-04       Impact factor: 3.444

6.  Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.

Authors:  Dawn Béraud; Hannah A Hathaway; Jordan Trecki; Sergey Chasovskikh; Delinda A Johnson; Jeffrey A Johnson; Howard J Federoff; Mika Shimoji; Timothy R Mhyre; Kathleen A Maguire-Zeiss
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-10       Impact factor: 4.147

Review 7.  Promiscuous Roles of Autophagy and Proteasome in Neurodegenerative Proteinopathies.

Authors:  Fiona Limanaqi; Francesca Biagioni; Stefano Gambardella; Pietro Familiari; Alessandro Frati; Francesco Fornai
Journal:  Int J Mol Sci       Date:  2020-04-24       Impact factor: 5.923

Review 8.  Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease.

Authors:  Stefano Gambardella; Francesca Biagioni; Rosangela Ferese; Carla L Busceti; Alessandro Frati; Giuseppe Novelli; Stefano Ruggieri; Francesco Fornai
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.